Arena Pharmaceuticals, Yext, IAC, and more

Business


Arena Pharmaceuticals Inc.: “We like Arena. We’ve liked it. I know it’s speculative. It’s O.K. for a spec, as long as you’re willing to understand that this is not Merck. “

IAC/InterActiveCorp.: “I thought that was an amazing quarter. I think that company is so inexpensive, I frankly don’t even understand it. I say it’s a buy, buy, buy.”

Yext inc.: “I like Y-E-X-T … I think the stock is a buy.”

Davita Inc.: “Why didn’t you just go into Abbott Labs? I mean honestly, Davita is way too volatile for me. I don’t know. Let it rally a little … but no, we don’t want Davita.”

Chemours Co.: “From the day it was spun off I didn’t like it. It had a nice little rally, it’s come back down. I don’t like it.”

WATCH: Cramer’s lightning round

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer’s world? Hit him up!
Jim Cramer TwitterFacebookInstagram

Questions, comments, suggestions for the “Mad Money” website? madcap@cnbc.com





Source link

Products You May Like

Articles You May Like

What it’s like to live on 123rd floor of world’s tallest condo tower
FedEx (FDX) earnings Q1 2020
Fintech firm posts third year of profit
Chewy shares slide despite narrower-than-expected second quarter loss
Adobe (ADBE) earnings Q3 2019

Leave a Reply

Your email address will not be published. Required fields are marked *